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Hajnalka Fenyvesi 1, Levente Emődy 1,4 and György Schneider 1,*
1 Department of Medical Microbiology and Immunology, University of Pécs Medical School, 7624 Pécs,
Hungary; Kovacs.judit2@pte.hu (J.K.K.); sbetti0101@gmail.com (B.S.); fenyvesi.hajnalka@pte.hu (H.F.);
levente.emody@aok.pte.hu (L.E.)
2 Department of Biotechnology, Nanophagetherapy Center, Enviroinvest Corporation, 7632 Pécs, Hungary;
Alysia.Cox@cshs.org (A.C.); kovacst@enviroinvest.hu (T.K.)
3 Institute of Plant Biology, Biological Research Center, 6726 Szeged, Hungary; marotig@baygen.hu
4 Veterinary Medical Research Institute, Hungarian Academy of Sciences, 1581 Budapest, Hungary
* Correspondence: schneider.gyorgy@pte.hu; Tel.: +36-72-536-200 (ext. 1908); Fax: +36-72-536-253
Received: 5 March 2020; Accepted: 1 April 2020; Published: 7 April 2020


Abstract: There are still major gaps in our understanding of the bacterial factors that influence
the outcomes of human Campylobacter jejuni infection. The aim of this study was to compare the
virulence-associated features of 192 human C. jejuni strains isolated from hospitalized patients with
diarrhoea (150/192, 78.1%), bloody diarrhoea (23/192, 11.9%), gastroenteritis (3/192, 1.6%), ulcerative
colitis (3/192, 1.5%), and stomach ache (2/192, 1.0%). Traits were analysed with genotypic and
phenotypic methods, including PCR and extracellular matrix protein (ECMP) binding, adhesion,
and invasion capacities. Results were studied alongside patient symptoms, but no distinct links with
them could be determined. Since the capacity of C. jejuni to invade host epithelial cells is one of its
most enigmatic attributes, a high throughput transcriptomic analysis was performed in the third
hour of internalization with a C. jejuni strain originally isolated from bloody diarrhoea. Characteristic
groups of genes were significantly upregulated, outlining a survival strategy of internalized C. jejuni
comprising genes related (1) to oxidative stress; (2) to a protective sheath formed by the capsule,
LOS, N-, and O- glycosylation systems; (3) to dynamic metabolic activity supported by different
translocases and the membrane-integrated component of the flagellar apparatus; and (4) to hitherto
unknown genes.
Keywords: Campylobacter jejuni; clinical isolates; genomic approach; virulence potential; intracellular
survival; transcriptomic analysis
1. Introduction
Campylobacter jejuni is regarded as a major cause of diarrhoeal diseases in both industrialised
and developing countries, mostly associated with the consumption of undercooked poultry
meat and contaminated surface water [1]. Campylobacter infections are increasing around the
world [2] with an annual average of 17 diagnosed cases per 100,000 people [3]. The clinical
spectrum of campylobacteriosis ranges from asymptomatic to severe symptoms, such as bloody
diarrhoea, sometimes embodied in post-infection sequelae, including Miller–Fisher and Guillain–Barré
syndromes [4,5].
To reduce and prevent Campylobacter infections in humans, it is crucial to understand those
virulence factors and molecular mechanisms that directly contribute to pathogenesis. There are still
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major gaps in our understanding, although the roles of major virulence properties, including its
chemotaxis, motility, spiral shape, adhesion, and invasion abilities, are known.
Numerous studies have documented the prevalence of specific coding regions in
pathogenicity-associated features in human and animal isolates and examined correlations between
their presence in the bacterial genome and disease severity [1,6–9], with controversial results.
After the early elucidation of the pivotal role of flagella in pathogenesis [10], systemic research
established that motility is based on a complex flagellar system built up by a membrane complex
(Class I or Early genes), a Hook protein (Class II or Middle genes), and a filament (Class III or Late
genes) [11]. The “corkscrew-like” motility [12,13] across the mucus membranes is facilitated by the
spiral shape that is a unique feature of campylobacters and helicobacters, and is strictly regulated,
leading to alterations in cell morphology of C. jejuni [14].
Adhesion is one of the most important factors contributing to colonization. C. jejuni binds first
to mucin, then to some extracellular matrix proteins (ECMPs), including fibronectin and laminin,
and finally directly onto the surface of epithelial cells. This process is facilitated by several factors, such as
CadF, Peb1, Peb2, Peb3, Peb4, CapA, CjaA, FlpA, FbpA, JlpA, DocA, and other new candidates [15–20].
It is evident that adhesion is a very complex process that is influenced by the variability of several
proteins, lipooligosaccharides (LOS), capsules (CPS) [21], and the unique O- or N-linked glycosylation
systems [22–25]. Based on gene content and organization of the LOS biosynthesis loci, the LOS classes
A, B, and C have been described [26]. Along with class-specific glycosyltransferases, these classes
possess neuBCA genes that are required for sialic acid biosynthesis and a cstII gene that encodes a sialic
acid transferase [26–28].
After successful colonization most C. jejuni strains have the capacity to invade upper epithelial
cells and have been shown to enter gut tissue cells in vivo and in vitro [29–33]. Previous observations
suggested that the invasion ability of an isolate could correlate with inflammation and the severity of
the clinical outcome [30]. In vitro cell culture methods, based on INT407, Caco, HeLa, and T84 cell
lines, have expanded our knowledge about the roles of specific cellular components in the invasion
process [15,19,34–38]. The importance of certain flagellar genes (flaA, flaB, flgB, flgE, and flaC) during
invasion is now known [39]. Although C. jejuni does not have a classical type III secretion system
(T3SS) [40], the flagellar apparatus fulfils this role [41] and its presence is required for maximal cell
invasion [39,42], and is also involved in the secretion and delivery of certain invasion antigens (CiaC
and CiaD) into the cytoplasm of epithelial cells [19,37,43]. Along with the flagellar genes, the role of
bacterial ABC transporter component PEB1 and an autotransporter protein CapA can mediate both
adherence and invasion in host epithelial cells [16,18]. The vast majority of research has focused on
the invasion of C. jejuni from the apical membrane, although some studies also demonstrated the
importance of the basolateral route [34], where not only fibronectin, but laminin and collagen IV as
well are present as potential adhesion targets [44].
Although Campylobacter produces several cytotoxins, only the cytolethal distending toxin (CDT)
has been studied in detail [45]. CDT induces cell cycle arrest and interleukin 8 (IL-8) secretion from
intestinal epithelial cells in culture by causing direct DNA damage, leading to progressive fragmentation
of the nucleus [46–50].
The factors that maintain survival of the internalized C. jejuni in eukaryotic cells are still unclear.
In contrast to other invasive bacteria, such as Listeria monocytogenes, Shigella flexneri, and Salmonella
typhimurium, internalization of C. jejuni into epithelial cells occurs by a trigger mechanism [33] in
a microtubule-dependent and actin-independent manner [51]. After internalization C. jejuni resides
within a membrane-bound compartment that does not fuse with lysosomes [52]. Unique metabolic
features, including the utilization of amino acids and organic acids as sole carbon sources [53] and
application of a highly branched electron transport chain, allow C. jejuni to respire not only oxygen,
but also other alternative electron acceptors [54,55]. How these processes functionally maintain
the intracellular lifecycle, and what molecular occurrences support this stage of infection, remain
elusive [55].
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One of the key differences between infection of humans and chickens by C. jejuni is the apparently
increased number of bacteria invading epithelial cells in the human host [56]. This suggests that both
bacterial adherence to and entrance into epithelial cells may be critical steps that are essential for
disease development [33].
Our aims with this study were (i) to assess the presence of known virulence-associated factors in
C. jejuni strains isolated from hospitalized patients with a wide variety of symptoms in South-West
Hungary; (ii) to reveal and compare the capacities of the isolates for ECMP binding, adhesion,
and invasion; and (iii) to evaluate how C. jejuni remains internalized by using whole transcriptomic
analysis (WTA). Deeper knowledge about the correlation of virulence attributes with clinical outcomes,
and about the genes expressed in the internalized C. jejuni cell, could reveal novel mechanisms and
facilitate the development of innovative control strategies.
2. Materials and Methods
2.1. Bacterial Strains and Growth Conditions
Altogether 192 C. jejuni strains were studied. A total of 190 C. jejuni isolates were collected from
human diarrheal and non-diarrheal stool samples by using the routine isolation and identification
method [57] in the Department of Bacteriology of the South Transdanubian Regional Public Health
Institute. Repeat isolates that were isolated from patients excreting other bacterial pathogens,
had known co-morbidity, received previous antibiotic therapy, or that were hospitalised for more
than 24 h at the collection of samples, as identified from the laboratory request forms, were excluded
from the study. Briefly, stool cultures were tested for Salmonella, Shigella, Yersinia, and thermophilic
Campylobacter by standard culture methods. Colony morphology, oxidase positivity, Gram staining
followed by microscopic morphology, and hydrolysis of hippurate and indoxyl acetate were applied
to identify C. jejuni. Strains were conserved at −80 ◦C in tryptic soy broth (TSB, Scharlab, Barcelona
Spain) containing 20% glycerol. Two wild-type reference strains (81–176 and NCTC 81116) were
used as controls. Isolates were grown on Charcoal Cefoperazone Deoxycholate Agar (CCDA) at
42 ◦C under microaerophilic conditions generated by the MACS–MICS jar-system (Don Whitley
Scientific, Shipley, UK). The jar system used the carbogen gas mixture (90% N2 and 10% CO2) to
create microaerophilic conditions. Bacteria were grown for 24 h prior to all experiments. Colonies
were collected, suspended, and their optical densities (OD) were synchronized to OD600 = 1 in
phosphate-buffered saline (PBS). Semisolid (0.3%) brain–heart infusion (BHI) agar (Oxoid, Hampshire,
UK) was used for motility tests. Strain CjTD-119 underwent transcriptional analysis in the third hour of
internalization. This strain was one of seven strains isolated from a patient with bloody diarrhoea and
showed high adhesion and high invasion. Before the study all 190 isolates were identified as individual
strains based on their SmaI macro restriction patterns performed by Pulsed Field Gel Electrophoresis
(PFGE) (https://www.cdc.gov/pulsenet/pdf/campylobacter-pfge-protocol-508c).
2.2. Polymerase Chain Reaction (PCR)
After 24 h growth on CCDA, bacterial cell counts were standardized by adjusting the OD600 to
1.0 (~4 × 108 CFU/ mL). Total DNA was prepared by boiling 1 mL bacterial suspension for 10 min.
The tested genes, primers, and annealing temperatures are listed in online Supplementary Table S1.
PCR was performed in a DNA Thermal Cycler (Eppendorf, Hamburg, Germany) using standardized
amplification parameters: 95 ◦C for 1 min for initial denaturation followed by 30 cycles of denaturation
at 95 ◦C for 30 s, various annealing temperatures for 2 min, and an elongation step at 72 ◦C for 2 min.
DNA bands were obtained with electrophoresis on 1% agarose gel, stained with ethidium bromide,
and visualized in the BioCapt Imaging System (BioRad, Hercules, California, USA).
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2.3. Solid-Phase Extracellular Matrix Protein (ECMP) Binding Assay
The solid-phase ECMP binding assay was performed as previously described [58] with slight
modifications. The following ECMPs were applied: fibronectin from human foreskin fibroblast
(Sigma-Aldrich, St. Louis, Missouri, USA), laminin (from Engelbreth–Holm–Swarm murine sarcoma
basement membrane, Sigma-Aldrich), and collagen type IV (from human placenta, Sigma-Aldrich).
Each well of the 96-well plates (Sarstedt, Nuembrecht, Germany) were filled with 100 µL aliquots
of 10 µg/mL fibronectin, laminin, and collagen type IV in PBS, respectively, followed by overnight
incubation at 4 ◦C. The next day wells were washed three times with 200 µL PBST (PBS, 0.5% 10
×Tween 20), and blocked with 100 µL 2% bovine serum albumin (BSA, Sigma-Aldrich) for 2 h at room
temperature. BSA was removed by washing the plates three times in PBST. Bacterial cells were grown
as defined above, harvested in PBS, and adjusted to OD600 = 1.0. To each well 100 µL of the bacterial
cell suspension was added and incubated at 37 ◦C for 3 h. Plates were washed three times with PBST,
filled with 1 mL 1% PBS-Triton X-100 (Sigma-Aldrich), and incubated at 37 ◦C for 10 min to detach
bound bacteria. The resuspended protein–bacterium complex (10 µL) was dropped and bled on CCDA.
After 48 h incubation under microaerophilic conditions at 42 ◦C, colony forming units (CFUs) were
counted, and the ratio of protein-binding ability was calculated. Pseudomonas aeruginosa was used as
a positive control, binding collagen type IV with 0.16%, fibronectin with 0.16%, and laminin with 0.1%.
2.4. INT 407 Binding and Internalization Assay
Adhesion and invasion analysis of the clinical strains was performed on semi-confluent monolayer
ATCC, INT 407 human embryonic intestine (jejunum and ileum) cell line (ATCC), on 24-well culture
plates. Semi-confluent cell monolayers were prepared (3 × 105 cells per well) in RPMI 1640 medium
(BioWhittaker, Lonza, Basel, Switzerland) supplemented with 10% heat-inactivated calf bovine serum
(Sigma-Aldrich), 10,000 U/mL penicillin, 10 µg/mL streptomycin, and 0.5 mg/mL neomycin, incubated
overnight at 37 ◦C in a humidified incubator with 5% CO2. The next day the bacterial suspensions with
various optical densities (OD600nm = 0.01, 0.1, and 1.0) were added to reach a multiplicity of infection
(MOI) ranging from 10 to 500 [45]. Plates were centrifuged at 100× g for 10 min at room temperature
and incubated at 37 ◦C with 5% CO2 for 3 h. For the adhesion and invasion assay, separate parallel
plates were used.
After incubation, plates for adhesion were washed three times with PBS followed by addition
of 1 mL Triton X-100 (Calbiochem/Sigma-Aldrich) solution (0.1% v/v) to solubilize the INT 407 cells.
To assess the total number of adhered and internalized bacteria, 10 µL aliquots of the suspended cells
were plated on CCDA and incubated under microaerophilic conditions for 48 h at 42 ◦C.
The gentamicin protection assay (GPA) was used to quantify the number of internalized
bacteria [59]. For invasion studies, after 3 PBS washes an additional incubation (60 min) with
1 mL RPMI with gentamicin (Aventis, Paris, France) at a bactericidal concentration (20 µg/mL) was
performed to kill the attached but not internalized bacteria. After washing the plates three times
with PBS, 1 mL Triton X-100 (0.1%) was added, and 10 µL volumes of the samples were plated as
described above.
To assess the number of adhered bacteria, the number of invaded bacteria (counted from the
gentamycin treated “invasion plates”) was subtracted from the total numbers of adhered and invaded
bacteria (counted from the “adhesion plates”). The adherence and invasive capacities were expressed
in percentages. Percentage adhesion values refers to the proportion of the total number of bacteria
added to the epithelial cells that adhered. Percentage invasion refers to the proportion of the total
number of adhered bacteria that were internalized [59].
2.5. Isolation of RNA from the Cultured and INT 407 Cell Invaded C. jejuni
A 3 h GPA invasion assay was carried out with C. jejuni strain CjTD-119 on the INT 407 cell line
by the technique described above. The same strain (24 mL OD600 = 1) was used as a control in RPMI
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(without the presence of the INT 407) incubated at 37 ◦C in a humidified incubator with 5% CO2
for 3 h. RNAprotect Bacteria Reagent (Qiagen, Hamburg, Germany) was used to stabilize the RNA
before collecting cells and trypsinization (Life Technologies, Carlsbad, California, USA) of the invaded
cells. Bacteria were centrifuged at 8000 × g for 15 min. Collected cells were homogenized in RNAzol
(Molecular Research Center, Cinncinatti, Ohio, USA) in a 1.5 mL microcentrifuge tube. The tubes
were dropped three times into liquid nitrogen (-196 ◦C) for more effective extraction of the RNA from
the intracellular bacteria. The total RNA concentration and purity was measured by an ND–1000
Spectrophotometer (Nanodrop, Thermo Scientific, Carlsbad, California, USA). The MICROBEnrich kit
(Life Technologies) was used to remove the eukaryotic RNA in the sample.
2.6. Sequencing C. jejuni Strain CjTD-119
A library from the isolated chromosomal DNA was prepared with a Nextera XT (Illumina, USA) kit
and sequenced on an Illumina MiSeq DNA sequencer using an Illumina V3 (600 cycles) kit. The average
coverage was 861x. Assembly occurred with the MyPro pipeline [60] and the contigs were further
assembled with Geneious 8 software (Geneious, Auckland, New Zealand). Validity of the assembled
larger contigs were tested by remapping the reads. The accession number of the deposited genome is
under the Bioproject PRJNA385384, with AMN06888245 NEWH00000000; Biosample SAMN06888245.
For multilocus sequence typing (MLST), sequences of the seven housekeeping genes (aspA, glnA, gltA,
glyA, pgm, tkt, and uncA) were uploaded to https://pubmlst.org/bigsdb?db=pubmlst_campylobacter_
seqdef&page=sequenceQuery.
2.7. Whole Transcriptome Analysis (RNA-Seq)
The total gene expression profiles of intracellular and control bacteria after 3 h incubation was
compared. RNA qualitative and quantitative measurements were implemented on Bioanalyzer
(Agilent Technologies, Santa Clara, California, USA) and Qubit (Life Technologies). High quality
(RIN > 8.5) total RNA samples from three biological replicates were pooled and processed using the
SOLiD total RNA-Seq Kit (Life Technologies), according to the manufacturer’s instructions. Briefly,
3 µg of pooled RNA was DNaseI treated, and the ribosomal RNA was depleted using the RiboZero
Prokaryotic rRNA Removal Kit (Illumina, San Diego, California, USA). The leftover was fragmented
using RNase III, the 50–200 nt fraction size-selected sequencing adaptors ligated, and the templates were
reverse transcribed using ArrayScript RT. The cDNA library was purified with the Qiagen MinElute
PCR Purification Kit (Qiagen), and size-selected on a 6% TBE–Urea denaturing polyacrylamide gel.
The 150–250 nt cDNA fraction was amplified using AmpliTaq polymerase and purified by AmPureXP
Beads (Beckman Coulter, Indianapolis, Indiana, USA). The concentration of each library was determined
using the SOLiD Library TaqMan Quantitation Kit (Life Technologies). Each library was clonally
amplified on SOLiD P1 DNA Beads by emulsion PCR (ePCR). Emulsions were broken with butanol,
and the ePCR beads enriched for template-positive beads by hybridization with magnetic enrichment
beads. Template-enriched beads were extended at the 3′ end in the presence of terminal transferase
and a 3′ bead linker. Beads with the clonally amplified DNA were deposited onto sequencing slides
and sequenced on a SOLiD5500XL Instrument (Thermo Fisher, Carlsbad, California, USA) using the
50-base sequencing chemistry.
2.8. Bioinformatics
Bioinformatic analysis of the whole transcriptome sequencing was performed in colour space
using the CLC Genomics Workbench (Qiagen). Raw sequencing data were trimmed by removal of low
quality, short sequences so that only 45–50 nucleotide-long sequences were used in further analysis.
Sequences were mapped onto their own (C. jejuni strain CjTD-119) genome sequence, using the default
parameters. Results were manually cured to remove false positive hits, which showed highly skewed
mapping of reads. Only genes detected with at least a 1.5-fold increase or decrease in transcription
levels after normalization were considered for further analysis.
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3. Results
3.1. The Presence of Putative Virulence Genes
PCR results of the distribution of the 14 putative virulence genes among the 192 C. jejuni isolates
are summarized in Figure 1. All strains possessed the toxin gene cdtB, the adhesion gene cadF, and the
flagellar system gene flgE2. Further flagellar genes (flaB, flhB, and flgB) involved in flagellar biosynthesis
were present in 96%, 97%, and 99% of the isolates, respectively, although all isolates proved to be motile.
docA and docB, with a role in colonization, were present in 90% of the isolates. The invasion-associated
genes iamA and ciaB were detected in 99% and 87% of the isolates, respectively. The virB11 gene was
found in two isolates implicating that these strains carried the pVir plasmid, also proven by plasmid
preparation (data not shown). The methyl-accepting chemotaxis protein coding gene, docC, was present
in approximately half of the strains. A similar distribution was revealed in the case of wlaN and cgtB
involved in LOS synthesis, 44% and 63%, respectively.
In order to identify isolates harbouring sialylated LOS, we tested for the presence of cstII and cstIII.
Many isolates were cstII-positive (35%), and only 16% of the strains were cstIII-positive. Altogether
49% of isolates were negative for both, cstII and cstIII. Finally, the hcp gene encoding for the type-6
secretion system (T6SS) was present in 27% of the tested isolates.
Figure 1. Percentage distribution of 14 previously described putative virulence genes in 190 C. jejuni
isolates. (See details in Supplementary Table S2).
3.2. Quantitation of the ECMP Binding Assay
C. jejuni isolates showed a high level of variability in ECMP binding capacity. Taking the binding
values 0.1% as the threshold of positivity, 16% of the strains were found to adhere to each of the three
ECMPs. Comparing the data (Supplementary Table S3), 5% of the strains were only able to bind
collagen type IV, 2.5% only to fibronectin, and 4% only to laminin. There was also a distribution among
the isolates in their preferred ECMP: 26% of the isolates bound collagen type IV at the highest level,
while 24% of the strains preferentially bound to fibronectin and 21% laminin. Twenty nine percent of
the isolates were unable to bind to any of the investigated ECMPs.
3.3. Adhesion and Invasion Abilities
Adhesion and invasion abilities varied considerably. From the distribution profile four classes of
relative invasiveness were defined (Table 1): (1) high adhesion but low invasion (e.g., CjTD-6, CjTD-100
and CjTD-120); (2) low adhesion but high invasion potential (e.g., CjTD-49, CjTD-64, and CjTD-94);
(3) high adhesion and high invasion potential (e.g., CjTD-35, CjTD-79, and CjTD-119); and (4) low
adhesion and low invasion (e.g., CjTD-16, CjTD-172, and CjTD-182). Altogether 5.3% of the tested
strains were able to adhere to INT 407 at a very high level, but they could not enter the cells in our
experimental setup. About 25% of the isolates could neither adhere to nor invade INT 407 cells. A total
of 3.7% of the strains were able to adhere to and invade INT 407 at a very high level. In Group 2, a high
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percentage (65.8%) of the adherent bacteria invaded the eukaryotic cells despite their relatively low
adhesion capacity. C. jejuni 81-176 and NCTC 81116 were used as reference strains for the adhesion
and invasion assays. Strain 81-176 is considered to have high invasion and adhesion ability [59].
The studied C. jejuni isolates were divided into four groups based on their abilities to adhere to and
invade INT 407 human intestinal epithelial cells compared to reference strains 81-176 and NCTC 81116.
Table 1. Adhesion/invasion capacity of the C. jejuni strains.
Group Different Adhesion/Invasion Potential % of Strains
Group 1 High adhesion/low invasion 5.3
Group 2 Low adhesion/high invasion 65.8
Group 3 High adhesion/high invasion 3.7
Group 4 Low adhesion/low invasion 25.2
3.4. Sequence of C. jejuni Strain CjTD-119
Sequence information of strain CjTD-119 was constructed to 14 contigs. MLST analysis based on
the seven housekeeping genes revealed that this isolate belongs to the clonal complex ST-42.
3.5. Bacterial Gene Expression during Invasion
Altogether 1668 open reading frames (ORFs) were detected with different fold changes and unique
gene reads. At the third hour of invasion the expression of 1121 genes was significantly affected: 963
were upregulated and 158 were downregulated (Figure 2). ORFs that were pathogenically important
and have the most significantly elevated genes are presented in Supplementary Table S2. Genes with
significantly elevated expression during invasion were identified and categorized according to their
functions. Each functional category was characterized by the dominance of genes with increased
expression. The ratio of decrease in each category ranged from 4% to 43%.
Results showed that 50% of the affected genes were involved in general biosynthesis/metabolism
and membrane functions, such as binding, transport, and translocation (Figure 2A). The expression
of several transmembrane proteins, such as Sec proteins (e.g.,: SecY (5.655), SecE (10.713), and SecG
(1.950)) [61], the Tol-dependent translocation system (TolB (1.749)) [62], and pore-forming channel
protein (OmpA (3.622)) [63] was elevated (Supplementary Table S2A). There was also elevated
expression of factors that were recently speculated to be involved in adhesion (Cj0268, Cj0090, Cj0091,
Cj1136, Cj0286c, Cj0379c, jlpA, capA, cjaA, flpA, fbpA, cadF, peb2, and peb3). However, expression of
adhesion protein coding genes peb1 and peb4 were not significantly altered.
There was increased expression (3.564x) of omp50, a hypothetical outer membrane porin. Cme genes
(e.g., cmeB (1.567) and cmeA (1.314)) coding for a Cme efflux pump proteins were upregulated except for
cmeC [64,65]. A transmembrane protein (AA01_00144/Cj0268c) required for adhesion and colonisation
in vitro [66,67] was elevated (2.881). Among the adhesion proteins (Supplementary Table S2B),
the determinants of four lipoproteins (JlpA, CapA, CjaA, and FlpA) were elevated at this later
stage of the invasion process. The two autotransporter proteins coded by capA (12.809) and capB
(5.124) were elevated, but because of their low unique gene reads, their expression values are only
indicative. The genes coding for fibronectin-binding adhesion proteins (flpA (2.909) and fbpA (2.160))
with possible roles in colonization [68] had elevated expression during the invasion. Two additional
lipoprotein-coding genes were overexpressed (AA01_01303/Cj0090) (1.879) and AA01_01302/Cj0091
(2.132), probably playing a role in adhesion and repressed by the CmeR regulator [65]. Expression of
the gene cj0588 involved in adhesion was also elevated [69]. We detected the increased expression of
peb3 (4.861) and peb2 (2.443), two genes coding for well-known adhesion proteins [70], and there was
increased expression of cadF (1.535), coding a highly characterized adhesion protein [15]. In contrast,
expression of genes coding for Peb1 [16] and Peb4 [17] proteins were not significantly elevated in the
third hour of invasion.
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Figure 2. Distribution of the affected functions and genes in the third hour of invasion of the highly
invasive strain CjTD-119. (A) Ratios of affected major functional groups (chart) and number of genes
compared to the whole gene pool (in brackets). (B) Distribution of the up- and downregulated
genes inside the major functional categories. Genes were assigned to the NCBI gene database.
See Supplementary Table S2 for more details.
All Mre-based bacterial cytoskeleton proteins responsible for the determination of bacterial cell
shape, including pbpC (4.455), mreC (2.831), pbpB (2.661), rodA (2.242), and mreB (1.533) [71], increased
in the internalized bacterium (Supplementary Table S2C).
A number of genes coding for surface-associated saccharides were elevated in the third hour
of invasion, including a group of capsular polysaccharide (CPS) genes (Supplementary Table S2D).
The genes kpsM and kpsE were overexpressed 4.2-fold and 1.9-fold, respectively. Expression of the gene
kpsT (3.897), coding for transport of capsule, and kpsC (3.447), responsible for capsule modification,
increased. Several LOS-related ORFs (Supplementary Table S2E) were upregulated, including the
biosynthetic genes galE (4.054), waaF (3.357), a glucosyltransferase (AA01_00523/Cj1135) (2.417),
gmhE (1.549), and lpxB (lipid A biosynthesis) (3.718) [72].
Several components of multiple iron uptake systems (iron-uptake ABC transporter ATP-binding
proteins, siderophore-mediated iron uptake system, ferrous iron transport proteins, and hemin uptake
system proteins) were also elevated (Supplementary Table S2F).
Genes belonging to the third major group (Figure 2A) are involved in nucleic acid metabolism.
The high prevalence of this mRNA indicates more intensive intracellular activity of C. jejuni inside the
eukaryotic cells during invasion than in normal culture conditions.
Hypothetical proteins were overexpressed in 138 of 1121 cases (Figure 2A, Supplementary Table
S2G), including a hypothetical sulfoxide reductase (AA01_00241/cj0379c), a glycosyltransferase (cj1136),
and a possible chemotaxis protein (AA01_00161/cj0286c) recently described in adhesion, invasion,
and colonisation [66,73,74].
Expression of the most important gene groups and some of their representatives in the internalized
C. jejuni are listed in Table 2.
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Table 2. Summary of the representative genes with significantly increased transcriptional activities at
the third hour of the invasion of strain CjTD-119.
Functional Group Significantly Upregulated Genes
Transmembrane Proteins
Sec protein system secE, secY, secG, secD, secF, yidC
Tol-dependent translocation system tolB
Pore forming channel proteins ompA, omp50
Cme efflux pump proteins cmeAB
Other transmembrane proteins cj0268c, lspA
Adhesion Proteins
Autotransporter proteins capA, capB
Fibronectin binding adhesion proteins flpA, cj1349c
Other adhesion proteins jlpA, cj0090, cj0091, cj0588, cadF
Bacterial Shape Determinant Genes
Mre-based bacterial cytoskeleton proteins pbpC, mreC, pbpB, rodA, mreB
Surface-Associated Saccharides
Capsular polysaccharide (CPS) kpsM, kpsT, kpsE, kpsC
Lipooligosaccharide (LOS) galE, waaF, Cj1135, gmhE, lpxB
Invasion Proteins
ATP-dependent protease lon, clpP
energy taxis receptors cetAB
Other invasion proteins cipAB, htrA, cj0497
Iron Acquisition
Iron-uptake ABC transporter ATP-binding proteins cfbpABC
The ferrous iron transport proteins feoAB
Hemin uptake system proteins chuBCD
Siderophore-mediated iron uptake system ceuCDE
Colonisation
Liv-system livJ, livK
Other colonisation Cj0561c, dnaJ, pldA, Cj0379c, docA
Regulatory Systems
Two-component regulatory (TCM) systems dccS
RacR–RacS system racS
FlgSR system flgR
Non TCM-system regulators spoT
Chemotaxis Genes cheB, cheW, cheV, cheR, cheA
Flagellar Machinery
Stator proteins motAB
Flagellar transport T3SS system flhAB, fliIPR
Motor switch proteins fliY
Energy Metabolism
Glycosylation System
“O”-linked glycosylation hisH, fabH2
“N”-linked glycosylation pglAEFK, wlaDJ
Respiration nuoACGIJKL
Protein Synthesis/Modification/Secretion ssrA, tilS
Invasion and colonisation-associated ORFs primarily comprised the “other” genes found
(5 genes, 6%). The expression of two invasion-related genes (cipA and ciaB) increased 2.6-fold
and 2.0-fold, respectively (Supplementary Table S2H), and a recently discovered lipoprotein coding
for AA01_01166/cj0497 was elevated (2.242) [74]. The two ATP-dependent protease-coding genes
lon (3.057) and clpP (1.931), which are involved in invasion and colonization at higher temperatures,
were also elevated [75] together with the serine protease coding htrA involved in adherence and
invasion [76]. The bipartite energy taxis receptors coded by cetA (2.329) and cetB (2.350) were
elevated [77]. A number of colonization-associated genes part of the Liv-system (livJ (4.207) and livK
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(4.639)), AA01_01544/cj0561c (3.052), dnaJ (3.705), pldA [78], AA01_00241/cj0379c (2.885) [73], and docA
(1.770) [79] were upregulated (Supplementary Table S2I).
Among the regulatory systems (Supplementary Table S2J), the two-component regulatory (TCM)
systems were elevated (dccS (2.638) and racS (1.733)) while the non TCM-system regulators showed
a slight decrease (cmeR (-1.644) and hspR (-1.441)) [80].
Overall, the toxin genes (Supplementary Table S2K) were downregulated while the chemotaxis
genes (Supplementary Table S2L) were upregulated.
An elevated oxidative stress response (Supplementary Table S2M) was detected (e.g., ahpC (1.670)
and sodB (1.532)) [81], although this value was not significant with katA (1.25). In contrast general
stress-response genes such as groES and groEL showed decreased expression.
A number of genes involved in “protein synthesis/modification” (Supplementary Table S2N)
were elevated during the internalization of bacteria. Beside many elongation factors, members of the
O-linked glycosylation (Supplementary Table S2O) and the N-linked glycosylation (Supplementary
Table S2P) [22,24] systems became activated.
The number of up- (28/1121) and downregulated genes associated with the flagellar machinery
were almost equal (Supplementary Table S2U), with early flagellar gene products (class I) being
overexpressed and class II and class III flagellar genes being under expressed (Supplementary
Figure S2).
4. Discussion
Despite its importance as a zoonotic agent and the availability of more than 1600 assembled
genomes (NCBI genome database), there is an incomplete understanding of C. jejuni pathogenesis.
The reason for that is when compared with other enteric bacterial pathogens, C. jejuni lacks many
virulence and colonization determinants that are typically used by bacterial pathogens to infect hosts.
Furthermore, C. jejuni has a broad repertoire of factors and pathways preferentially used to establish
commensalism in any animal hosts and to promote diarrheal disease in the human population [55].
These flexible properties of C. jejuni are encoded in a relatively small genome (~2.2 MB) that further
enhances the complexity of C. jejuni.
The ability of each of our 190 clinical isolates to spread on the BHI semisolid agar confirmed
the pivotal role of flagella in C. jejuni infection [10]. Since loss of flaB, flhB, and flgB was reported to
lead to a non-motile phenotype [39], the 96%, 97%, and 99% distribution of these genes (Figure 1)
could be the result of a small nuclear polymorphism (SNP) in the primer [82,83] binding regions of the
affected isolates.
Flagella represent a typical virulence factor with multiple roles during pathogenesis. Beside its
role in motility [10] and cell invasion induction as a T3SS-like transport apparatus [39], the high rate
of expression of the early class flagellar gene products (Supplementary Table S2U) coding for the
transmembrane complex of flagellar transport and stator proteins [11,42] (Supplementary Figure 2),
indicated its transport function, also in the internalized bacterium cell.
The 100% prevalence of cdtB in the investigated isolates is in agreement with previous data
showing that CDT genes were highly abundant (90%–100%) if the isolate was of human or animal
origin [7,84–86]. We could not confirm that CDT was associated with local acute inflammation [87],
but lack of correlation between its presence and the clinical symptoms does not support that this toxin
has a decisive role in the clinical outcome. This is in full agreement with a recent study that showed
that campylobacteriosis caused by CDT-negative strains was clinically indistinguishable from patients
infected with an isolate that produced high levels of CDT [88]. In connection with CDT of C. jejuni it
was also hypothesized that the presence of this toxin was associated with increased adherence and
invasion to HeLa cells [85]. Our results disprove these findings, since aside from the 100% presence of
gene cdtB, isolates showed discrepancies among their adhesive and invasive potentials.
Determining the link between putative virulence factors and the manifested clinical symptoms
with C. jejuni remains difficult. High prevalence of cadF (100%), iamA (99%), docA (90%), and ciaB (87%)
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in our strain collection highlighted the potential importance of these genes in C. jejuni pathogenesis and
survival. This was indicated in previous genetic studies examining their presence among poultry, cattle
and human isolates [7,8,89,90]. CdtABC, cadF, docA, and iamA were detected in 98%–100%, 98%–100%,
94%, and 1.6%–92% of the human isolates, respectively [7,8,89,90]. The hcp gene, coding for the Type
VI secretion system (T6SS), was recently suggested as a potential new player. It was reported to have
a role in survival and pathogenesis of Campylobacter spp. [91]. Its relatively low (27%) prevalence,
however, contradicts its crucial role in the pathogenic process, although its presence was higher (39%,
9/23) among bloody diarrhoea isolates compared to diarrhoea cases (23%, 33/140) (Supplementary
Table S3). The hcp gene was also present in both registered clinical cases of stomach ache. Nevertheless,
our results (27%) were in line with a previous study based on retail chicken isolates from Northern
Ireland [92].
Controversial results were also obtained in recent studies when combinations of virulence factors
were investigated, including cdt and iam [93]. Phenotypic tests (e.g., adhesion and invasion) are
one possible method to elucidate potential roles of different factors or their combinations in C. jejuni
pathogenesis. For that purpose, we performed a study with high strain numbers and both genetic and
phenotypic analyses.
ECMP binding is one of the first steps of colonization of C. jejuni pathogenesis [25]. Binding of
fibronectin, a major ECMP secreted by epithelial cells, and the subsequent signalling processes were
demonstrated as an essential step of internalization and preferentially occurred at the basolateral cell
surface [34]. Therefore, we investigated the binding potential of C. jejuni strains to other characteristic
ECMPs in basal lamina, including laminin and type IV collagen. There was a lack of correlation between
fibronectin adhesion potential [34,94] and adhesion onto INT 407 cells, confirming that the adhesion
process of these 192 strains of C. jejuni is a multicomponent process involving several simultaneously
occurring attachment mechanisms [58]. However, our results clearly suggest that other ECMPs, such as
laminin and type IV collagen, could further facilitate the adhesion process either in at the basolateral
invasion route or the transepithelial infection route, potentially causing bacteraemia.
An arsenal of genes (jlpA, capA, cjaA, flpA, fbpA, cadF, cj0268, cj0090, cj0091, cj1136,
cj0286c, and cj0379c) have previously been confirmed or suggested to play a role in C. jejuni
adhesion [14–17,19,20,68]. The large differences between the adhesion potentials of ECMPs and
INT 407 cells was in harmony with recent findings focusing on the adhesion potentials of C. jejuni
isolates from different origins to biotic and abiotic surfaces [95,96]. The diverse protein composition
expressed on the surface of individual isolates could strongly influence adhesion potential and
thereby affect the outcome of infections [58]. This was further complicated by the fact that C. jejuni
host-cell interactions are strongly influenced by lectin–glycan interactions, mediated by LOS and
glycoproteins [22–25]. Recent studies demonstrated the importance of sialylated LOS in invasion [97],
an increased occurrence of bloody diarrhoea, and a longer duration of symptoms [98,99]. Our findings
did not reveal any correlation between the presence of cstII and cgtB [28,100] and the invasive potential
and clinical outcomes of the isolates as previously demonstrated [101]. However the high rate
of expression of various synthases, transferases, and epimerases that take part in LOS synthesis
(Supplementary Table S2E) and O- and N-linked glycosylation (Supplementary Table S2O,P) strongly
suggest that these systems have supportive roles in maintaining intracellular C. jejuni survival.
Due to the abovementioned differences in putative virulence factors [55] among the C. jejuni
isolates, it is not surprising that our adhesion and invasion capacity findings were in harmony with
recent data [102] where adhesion and invasion potentials of 34 retail meat C. jejuni isolates ranged
across a large scale.
Epithelial cell invasion is thought to be an essential step in C. jejuni infection [103,104] and
correlates with the severity of clinical symptoms [32]. The ability of C. jejuni to invade cultured cells is
strain dependent [30,105,106] and in vitro data indicates the presence of non-invasive but pathogenic
C. jejuni isolates [107]. The two non-invasive strains, both of them isolated from simple diarrhoea in
our strain collection (Supplementary Table S3), are under further study.
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However intracellular survival is a typical feature of C. jejuni and remains one of the most
intriguing aspects of its infection with several unknown molecular occurrences. For our transcriptomic
study the non-polarized INT 407 epithelial cell line was used, as it is one of the most widely used
model systems to investigate C. jejuni–host cell interactions and invasion [15,19,35,37,38].
The high expression of the abovementioned adhesion factors in the third hour of infection could
reflect that these molecules somehow support the stabilisation of vacuole internalisation in the epithelial
cell line INT 407. Our results support the dual (adhesion and invasion) role of these proteins during
pathogenesis. In contrast, the insignificant elevation of Peb1 [16] and Peb4 [17] clearly indicate their
role is limited to adhesion without affecting intracellular life.
Internalisation drives the bacterium into a novel and stressful environment [108]. Although
there is little data available about the stress response evoked by invasion in C. jejuni, the general
increase in the oxidative stress response genes (katA, ahpC, sodB, and dps), and decrease in general stress
response genes (groES, groEL, and dnaK) strongly suggested that inside the Campylobacter-containing
vacuoles (CCV), the bacterial cell encountered an oxidative environment. Furthermore, the molecular
defensive mechanism of the host cells includes release of various reactive oxygen species, including
superoxide, hydrogen peroxide, and halogenated oxygen molecules. Although CCV does not fuse
with the lysosome [109], there is an activation of the oxidative stress response genes [110] contributing
to radical inactivation.
Recent studies reported that during oxidative stress conditions, C. jejuni transformed its spiral
shape to a coccoid one [81]. Although we did not evaluate the morphological state of the internalized
C. jejuni, decreased expression of pgp1 and pgp2 [13,111], two genes contributing to the helical cell
shape, suggested that the bacterium lost its curved shape in the vacuole. In the rod shape formation,
there is increased expression of penicillin-binding protein genes (pbp) [71,112], supporting our findings
as elevated expression levels of pbpA, pbpB, and pbpC in the internalized C. jejuni following 3 h of
internalisation were detected (Supplementary Table S2C). The increased expression levels of the
Mre-based cytoskeletal and rod shape determining proteins (MreB, MreC and RodA) strengthen
this hypothesis.
C. jejuni is unusual for an intestinal pathogen in its ability to coat its surface with a CPS [113],
and although capsules are virulence factors for other pathogens, the role of CPS in C. jejuni disease
has not been well defined [113,114]. This polysaccharide structure may be necessary at the beginning
of the bacterial interaction with the mucus layer, but it may be followed by downregulation of CPS
production, leading to exposure of bacterial adhesins [25,115]. Overexpression of some crucial genes
linked to surface-associated saccharide production and transport (kpsM (4.240), kpsE (1.882), kpsT (3.897),
and kpsC (3.447); Supplementary Table 2/D), and the fact that use of the intracellular route could be
an important pathogenic feature of C. jejuni, suggested that CPS could support intracellular survival
and therefore contribute to virulence. This could be one explanation why capsule mutants showed
a modest reduction in invasion of intestinal epithelial cells in vitro [116–118].
Similar to CPS, the expression of LOS structures showed an increase in the internalized C. jejuni cell
(Supplementary Table 2E). Aside from colonization, LOS effectively protects the bacterial cell against
small molecules, including β-defensins, polymyxin [119], hydrophobic molecules [120], and phenolic
compounds [121]. The increased expression of associated genes (Supplementary Table S2E) indicates
that the vacuolized C. jejuni cell protected itself by thickening its LOS, along with the CPS. This response
to hostile environments is a typical feature of biofilm-forming bacteria.
Adaptation to the above-presented synthetic processes and to the novel environment surrounding
the bacterial cell requires accelerated transcriptomic activity. Increased expression of several genes
encoding regulatory and signal transduction proteins (Supplementary Table S2J) and metabolism
(Supplementary Table S2N) indicated these processes. From our results it was evident that at least
six regulators positively maintained the internalized state of C. jejuni. The upheaval of 90% of the
metabolic genes indicated the production of novel proteins (Supplementary Table S2N), with dominance
of biosynthetic and metabolic (244/279), energy metabolic (29/35), and protein synthetic (51/53)
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genes (Figure 2B). The moderate but characteristic transcriptional increase of the subunits of the
NADH-quinone oxidoreductase (Supplementary Table S2Q) supports this process by pumping protons
accumulated from metabolic processes across the plasma membrane [122], increasing ATP synthesis.
An increase in membrane and transport protein expression strongly suggests that the bacterium
did not separate itself from its environment as in case of the viable but non-culturable (VBNC)
form [123], but actively interacted with it. The high expression of genes (secY (5.655), secE (10.713),
and secG (1.950)) associated with the evolutionarily conserved heterotrimeric membrane channel
SecYEG supports this hypothesis, as most proteins trafficking across or into the bacterial cytoplasmic
membrane occur via the translocon system, formed by the three Sec proteins [61]. This process could be
further supported by two partially characterized translocases like tolB (1.749) [62] and ompA (3.622) [63]
(Supplementary Table S2A). The elevated level of iron transporters (Supplementary Table S2F) indicates
that iron is also a limiting factor in the vacuole, similar to other pathogen–host interactions [124].
This study aimed to find correlations between the presence of (i) putative virulence genes,
(ii) results of the phenotypic assay, and (iii) clinical symptoms by comparing the features of 192
C. jejuni human isolates. Despite the large sample size, we revealed no strong correlation between
the genetic determinants of the investigated putative virulence factors, phenotypic characteristics,
and clinical symptoms. Results of the subsequent transcriptomic analysis performed 3 h after invasion
outlined the major characteristics of internalized state of C. jejuni: 1) elevation of the oxidative stress
response genes in response to the oxidative condition in CVV; 2) a protective sheath formed around the
internalized C. jejuni cell using several cell structures and mechanisms, including capsule, LOS, N- and
O- glycosylation systems; and 3) the internalized state is not a static, but a dynamic one maintained
by different translocases and the membrane-integrated part of the flagellar apparatus. Furthermore,
several genes with hypothetical or unknown functions were active, and warrant further study.
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